Johan Frieling has recently been appointed as the new chief medical officer of Micreos. EPM talks to him about his experience in the pharmaceutical sector and the company’s new antibiotic alternative, Staphefekt...
Micreos' chief medical officer talks to EPM about antibiotic alternatives.
Share this article
Bekijk een volgend artikel
Staphefekt is featured in The Biomedical Scientist as being the first effective alternative to antibiotics for suppression of S. aureus on the skin.
Prevalence and odds of Staphylococcus aureus carriage in atopic dermatitis: a systematic review and meta-analysis